Bioorganic and Medicinal Chemistry
We previously described a series of 314-helical β-peptides that bind the hDM2 protein and inhibit its interaction with a p53-derived peptide in vitro. Here we present a detailed characterization of the interaction of these peptides with hDM2 and report two new β-peptides in which non-natural side chains have been substituted into the hDM2-recognition epitope. These peptides feature both improved affinity and inhibitory potency in fluorescence polarization and ELISA assays. Additionally, one of the new β-peptides also binds the hDM2-related protein, hDMX, which has been identified as another key therapeutic target for activation of the p53 pathway in tumors.
Copyright © 2009 Elsevier Ltd. All rights reserved.
National Institutes of Health (GM 74756) and the National Foundation for Cancer Research
Harker, Elizabeth A.; Daniels, Douglas S.; Guarracino, Danielle A.; and Schepartz, Alanna S., "Beta-peptides with improved affinity for hDM2 and hDMX" (2009). Chemistry Faculty Publications. 94.
The document available for download is the authors' accepted manuscript, provided in compliance with the publisher's policy on self-archiving. Permission documentation is on file. To read the version of record, use the DOI provided.